↓ Skip to main content

Cochrane Database of Systematic Reviews

Addition of intravenous aminophylline to inhaled beta2‐agonists in adults with acute asthma

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
7 X users
facebook
2 Facebook pages
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
221 Mendeley
Title
Addition of intravenous aminophylline to inhaled beta<sub>2</sub>‐agonists in adults with acute asthma
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd002742.pub2
Pubmed ID
Authors

Parameswaran Nair, Stephen J Milan, Brian H Rowe

Abstract

Asthma is a chronic condition in which sufferers may have occasional or frequent exacerbations resulting in visits to the emergency department (ED). Aminophylline has been used extensively to treat exacerbations in acute asthma settings; however, it's role is unclear especially with respect to any additional benefit when added to inhaled beta(2)-agonists.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 221 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 1 <1%
Chile 1 <1%
Colombia 1 <1%
Unknown 218 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 28 13%
Researcher 25 11%
Student > Bachelor 19 9%
Student > Ph. D. Student 13 6%
Other 12 5%
Other 43 19%
Unknown 81 37%
Readers by discipline Count As %
Medicine and Dentistry 83 38%
Nursing and Health Professions 17 8%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Agricultural and Biological Sciences 6 3%
Psychology 4 2%
Other 13 6%
Unknown 89 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2023.
All research outputs
#3,705,510
of 25,460,914 outputs
Outputs from Cochrane database of systematic reviews
#6,281
of 12,090 outputs
Outputs of similar age
#35,239
of 286,587 outputs
Outputs of similar age from Cochrane database of systematic reviews
#86
of 197 outputs
Altmetric has tracked 25,460,914 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,587 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 197 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.